Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa.

Lissitchkov, Toshko; Willemze, Annemieke; Jan, Christelle; Zilberstein, Moshe; Katragadda, Suresh

Lissitchkov, Toshko; Willemze, Annemieke; Jan, Christelle; Zilberstein, Moshe; Katragadda, Suresh.

Afiliação

Lissitchkov T; Specialized Hospital for Active Treatment of Hematological Diseases, Department of Chemotherapy, Hemotherapy and Hereditary Blood Diseases at Clinical Hematology Clinic, Sofia, Bulgaria.
Willemze A; Sanofi, Amsterdam, The Netherlands.
Jan C; Sanofi, Chilly-Mazarin, France.
Zilberstein M; Sanofi, Bridgewater, New Jersey, USA.
Katragadda S; Sanofi, Cambridge, Massachusetts, USA.

Res Pract Thromb Haemost ; 7(4): 100176, 2023 May.

Article em En | MEDLINE | ID: mdl-37538505